Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells
Open Access
- 10 October 2017
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 108 (12) , 2405-2412
Abstract
Identification of specific drug targets is very important for cancer therapy. We recently identified zinc finger protein of the cerebellum 5 (ZIC5) as a factor that promotes melanoma aggressiveness by platelet‐derived growth factor D (PDGFD) expression. However, its roles in other cancer types remain largely unknown. Here we determined the roles of ZIC5 in prostate cancer (PCa) and colorectal cancer (CRC) cells. Results showed that ZIC5 was highly expressed in CRC and dedifferentiated PCa tissues, whereas little expression was observed in relevant normal tissues. Knockdown of ZIC5 decreased proliferation of several PCa and CRC cell lines with induction of cell death. ZIC5 knockdown significantly suppressed PDGFD expression transcriptionally, and PDGFD suppression also decreased proliferation of PCa and CRC cell lines. In addition, suppression of ZIC5 or PDGFD expression decreased levels of phosphorylated focal adhesion kinase (FAK) and signal transducer and activator of transcription 3 (STAT3) which are associated with PCa and CRC aggressiveness. Furthermore, knockdown of ZIC5 or PDGFD enhanced death of PCa and CRC cells induced by the anti‐cancer drugs docetaxel or oxaliplatin, respectively. These results suggest that ZIC5 and PDGFD promote survival of PCa and CRC cells by enhancing FAK and STAT3 activity, and that the roles of ZIC5 are consistent across several cancer types.Keywords
Funding Information
- Japan Society for the Promotion of Science (‘17H05056’, ’26293071’, ’26860221’)
- Uehara Memorial Foundation
- Tokyo Biochemical Research Foundation
This publication has 29 references indexed in Scilit:
- Mechanisms of intrinsic and acquired resistance to kinase‐targeted therapiesPigment Cell & Melanoma Research, 2012
- Differential Tumorigenic Potential and Matriptase Activation between PDGF B versus PDGF D in Prostate CancerMolecular Cancer Research, 2012
- Chemoprevention, chemotherapy, and chemoresistance in colorectal cancerDrug Metabolism Reviews, 2012
- β-Catenin Inhibits Promyelocytic Leukemia Protein Tumor Suppressor Function in Colorectal Cancer CellsGastroenterology, 2012
- Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotypeCell Cycle, 2008
- Hsp60 Regulation of Tumor Cell ApoptosisJournal of Biological Chemistry, 2008
- C‐terminal phosphorylation controls the stability and function of p27kip1The EMBO Journal, 2006
- Structural and functional specificities of PDGF‐C and PDGF‐D, the novel members of the platelet‐derived growth factors familyThe FEBS Journal, 2005
- mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4EMolecular and Cellular Biology, 2004
- Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarraysOncogene, 2003